HEALTH TOPICS 
Hormone therapy for prostate cancer
Editor in Chief Marc B. Garnick, M.D.,* discusses the options and controversies
|
*Disclosure "" Dr. Garnick is currently serving as a consultant to SpecialtyEuropeanPharma, which is developing abarelix in Europe. |
To continue reading this article, you must login.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise